Intercept Pharmaceuticals IncのEV/EBIT
Intercept Pharmaceuticals IncのEV/EBITは何ですか。
Intercept Pharmaceuticals IncのEV/EBITはN/Aです。
EV/EBITの定義は何ですか。
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
NASDAQのセクタHealth CareにおけるEV/EBITの企業と比べるIntercept Pharmaceuticals Inc
Intercept Pharmaceuticals Incは何をしますか。
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Intercept Pharmaceuticals Incと類似のev/ebit
- Country Club Hospitality & HolidaysのEV/EBITはN/Aです。
- AF2 CapitalのEV/EBITはN/Aです。
- Relmada Therapeutics IncのEV/EBITはN/Aです。
- Emerge CommerceのEV/EBITはN/Aです。
- Bank of Marin BancorpのEV/EBITはN/Aです。
- Vita 34 AGのEV/EBITはN/Aです。
- Intercept Pharmaceuticals IncのEV/EBITはN/Aです。
- RaminfoのEV/EBITはN/Aです。
- PerceptronのEV/EBITはN/Aです。
- Suven Life SciencesのEV/EBITはN/Aです。
- Morarjee TextilesのEV/EBITはN/Aです。
- Crinetics Pharmaceuticals IncのEV/EBITはN/Aです。
- Ramky InfrastructureのEV/EBITはN/Aです。